Radiometer Medical has announced the addition of Troponin T (TnT) to its AQT90 FLEX immunoassay analyzer, which can be used to test for biomarkers at the point of care. Troponin T is released by damaged heart tissue after a heart attack, and its presence in the bloodstream is commonly used as an indicator of acute myocardial infarction (AMI). However, while detection of a heart attack is time sensitive, it can often take well over an hour to get the results of a lab test for TnT. Radiometer hopes their platform will improve patient outcomes by providing much faster turnaround time.
From the press release:
On the AQT90 FLEX, TnT results are available at the point of care in just 12 minutes, enabling caregivers to meet recommended guidelines. Because testing is done directly on whole blood and is mostly automated, there is no need for cartridge and sample preparation.
Compliance is key when providing test results at the point of care. With a correlation of 0.999 to the Roche Elecsys 2010 troponin T 4th generation assay and a correlation of 0.993 to the Roche Elecsys 2010 troponin T 5th generation assay, TnT measured on the AQT90 FLEX shows a performance comparable to lab assays at the point of care.
Press release: AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin T at the Point of Care…
Product page: Understanding the AQT90 FLEX immunoassay…
